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Interleukin-1 (IL-1) is the principal pro-inflammatory cytokine participating in the initiation of acute phase response. Human hepatoma
HepG2 cells were exposed to 15 ng/ml of IL-1beta for times ranging from 1 to 24 h and the total RNA was isolated. Then cDNA was
obtained and used for differential display with 10 arbitrary primers and 9 oligo(dT) primers designed by Clontech. Validation of observed
changes of differentially expressed known genes was carried out by RT-PCR or Northern blot analysis. Out of 90 cDNA strands modulated
by IL-1, 46 have been successfully reamplified and their sequencing indicates that they represent 36 different cDNA templates. By GenBank
search, 26 cDNA clones were identified as already known genes while 10 showed no homology to any known gene. The identified transcripts
modulated by IL-1 in HepG2 cells code for intracellular proteins of various function: trafficking/motor proteins (3 genes), proteins
participating in the translation machinery or posttranscriptional/posttranslational modifications (7 genes), proteases (1 gene), proteins
involved in metabolism (6 genes), activity modulators (3 genes), proteins of the cell cycle machinery (2 genes) and those functionally
unclassified (4 genes). Majority of genes responded to IL-1 within 1 to 6 h (early genes), while two were late response genes (12–24 h) and
four showed prolonged response over the whole 24-h period. Most of the observed changes of expression were in the range of two- to
threefold increase in comparison to control untreated cells. Among identified genes, no typical secretory acute phase protein was found. The
obtained results suggest that IL-1 affects the expression of several genes in HepG2 cells, especially those engaged in the synthesis and
modifications of proteins.
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1. Introduction [3]), but relatively little is known about cytokine-inducedThe principal cytokines initiating the inflammatory reac-
tion include interleukin-1 beta (IL-1h), tumor necrosis factor
alpha (TNFa) and interferon gamma (IFNg), whereas IL-6
and related cytokines are held responsible for enhanced
production of acute phase proteins in the liver cells [1,2].
Although the inflammatory and acute phase responses are
highly complex phenomena, they can be analysed in a model
system of cell culture stimulated by cytokines. Rat and
human liver cell cultures provided a plethora of data on the
mechanism of induced synthesis of plasma proteins (see Ref.0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2004.03.002
Abbreviations: IL-1h, interleukin-1 beta; TNFa, tumor necrosis factor
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E-mail address: koj@mol.uj.edu.pl (A. Koj).changes in the expression of intracellular proteins of hep-
atocytes. Moreover, the role of IL-1 in hepatocyte metabo-
lism and liver-specific gene expression has only been
partially elucidated and is limited to some acute phase
proteins [4].
So far, very few comprehensive studies have been con-
ducted with the aim at finding all genes involved in the
acute phase reaction in the liver cells. Olivier et al. [5]
investigated the liver acute phase response by subtractive
hybridization after injecting rats with Freunds adjuvant. The
authors identified genes coding for 23 known acute phase
proteins, 31 genes coding for other proteins up to now not
related to the inflammatory response, and 36 novel proteins
of unknown function. The adult human liver transcriptome
was analysed by cDNA array hybridization by Yano et al.
[6]. A total of 2418 gene transcripts were assigned to the
liver tissue obtained by surgical biopsy from five subjects.
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model acute phase response. Clearly, the results obtained by
Olivier et al. [5] and Yano et al. [6] derive from a complex
system in which the involvement of individual cytokines
cannot be properly evaluated. For this reason, we decided to
use highly differentiated human hepatoma HepG2 cells that
are known to respond to several cytokines in a manner
similar to liver cells (see Ref. [7]). HepG2 cells were
cultured in vitro and treated with relatively low doses of
IL-1h in order to simulate the initial stages of the inflam-
matory response. The culture was maintained for time
periods ranging from 1 to 24 h after exposure to IL-1 and
differential display method was used to characterize changes
in the transcript profile. A preliminary report of these studies
was presented during 30th Annual Conference ‘‘Progress in
Molecular Biology’’ in Zakopane [8].2. Materials and methods
2.1. Cell culture
HepG2 cells (from ATCC, passages 11-16) were cultured
at 37 jC and 5% CO2 in Dulbecco Modified Eagle Medium
(DMEM) with 1000mg/l D-glucose (Gibco/BRL) supple-
mented with 10% foetal bovine serum (FBS), 2.5 Ag/ml
plasmocin (Invivogen). Cells were grown in plastic Petri
dishes (10 cm in diameter, TPP, Switzerland) to approxi-
mately 70% confluence. At 15 h before IL-1h treatment,
they were washed twice in PBS and placed in DMEM
containing 0.5% FBS without plasmocin. Then cells were
stimulated with human IL-1h (kindly provided by Dr. C.
Dinarello, Denver, CO, USA) at a final concentration of 15
ng/ml for different time periods (1, 2, 4, 6, 12, 18, 24 h).
The responsiveness of cells to IL-1h was demonstrated by
increased levels of mRNA coding for manganese superox-
ide dismutase and by modulation of IL-6 signalling as
reported elsewhere [9].
2.2. Differential display analysis
Total RNA was isolated from unstimulated (control) and
IL-1-stimulated cells according to the Chomczynski and
Sacchi [10] method. Briefly, cells were treated with GTC
solution (4 M guanidinum thiocyanate, 25 mM sodium
citrate pH 7.0, 0.5% sarcosyl, 0.1 M 2-mercaptoethanol)
and extracted with phenol/chloroform/isoamyl alcohol
(25:24:1), RNA precipitated with isopropyl alcohol, washed
with 70% ethanol and the pellet was dissolved in DEPC-
treated water. The first strand of cDNA was synthesized
from 5 Ag of total RNA in 20 Al using SuperScript
RNaseHreverse transcriptase (Promega). Reaction mix-
tures were diluted five times and then 5 Al was taken to
the differential display analysis. Primers used in the PCR
reaction (10 arbitrary primers and 9 oligo(dT) primers) were
designed by Clontech.Sequences of arbitrary primers: p1: attaaccctcactaaa-
tgctgggga; p2: attaaccctcactaaatcggtcatag; p3: attaaccctcac-
taaatgctggtgg; p4: attaaccctcactaaatgctggtag; p5: attaaccc-
tcactaaagatctgactg; p6: attaaccctcactaaatgctgggtg; p7:
attaaccctcactaaatgctgtatg; p8: attaaccctcactaaatggagctgg; p9:
attaaccctcactaaatgtggcagg; p10: attaaccctcactaaagcaccgtcc.
Sequences of oligo(dT) primers: t1: cattatgctgagtga-
tatctttttttttaa; t2: attatgctgagtgatatctttttttttac; t3: cattatgctgagt-
gatatctttttttttag; t4: cattatgctgagtgatatctttttttttca; t5:
cattatgctgagtgatatctttttttttcc; t6: cattatgctgagtgatatctttttttttcg;
t7: cattatgctgagtgatatctttttttttga; t8: cattatgctgagtga-
tatctttttttttgc; t9: cattatgctgagtgatatctttttttttgg.
After three low-stringency cycles (94 jC–1 min; 40 jC–
1 min;72 jC–5 min) 25–30 high-stringency cycles were
done (94 jC–1 min; 55 jC–1 min;72 jC–1 min). The
amplified cDNA fragments were separated by electropho-
resis on polyacrylamide gels (200 200 1 mm) with 4%
concentration of upper half and 6% of lower half of the gel
to separate fragments of 200–2500 bp. The PCR products
were visualised by the silver staining method.
2.3. Band recovery and sequence analysis
Differentially expressed amplified cDNA fragments were
excised from the dried gel, soaked in water and reamplified
using the same set of primers as in original PCR. After
agarose gel purification (Qiagen) PCR products were cloned
to pTZ57R vector from InsT/A clonek PCR product
cloning kit (Fermentas). After transformation, three clones
from each bacterial plate were checked by restriction anal-
ysis using EcoRI and HindIII restriction enzymes. One of
the analysed clones was sequenced using PCR sequencing
method and a primer labelled with [g32P]dATP according to
the manufacturer (Perkin Elmer).
2.4. Computational analysis
Sequences of differentially expressed genes were deter-
mined by searching the GenBank data at the National Center
for Biotechnology Information using BLAST program.
2.5. RT-PCR
Validation of observed changes of differentially
expressed known genes was carried out by semiquantitative
RT-PCR or Northern blot analysis. PCR primers were
designed on the basis of data obtained in cycle sequencing
and GenBank data. The sequence of reverse transcriptase-
PCR (RT-PCR) primers is available from the authors on
request. cDNA was prepared from 1-Ag RNA isolated from
the control sample or after IL-1h stimulation for different
time periods (1, 2, 4, 6, 12, 18, 24 h). Amplification
consisted of 25 cycles with fivefold diluted cDNA. RT-
PCR samples (8 Al) were electrophoresed through a 1.5%
agarose gel. All RT-PCR products were verified by measur-
ing the amounts of elongation factor 2 (EF2) transcript in
Fig. 1. Differential display analysis. A representative picture of DD-PCR
products separated on polyacrylamide gels and detected by the silver
staining procedure. In this particular case, PCR reaction was done with
primers P1/T7. One of the differentiated bands (marked with an arrow)
represents the cDNA fragment encoding RPL19.
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specific primers. PCR products were visualised by ethidium
bromide staining and the changes in gene expression were
measured using Multiimage Scanner and software Quantity
One (BioRad).
2.6. Northern blot analysis
Total RNAwas isolated from control and IL-1-stimulated
cells (after 1, 2, 4, 6, 12, 18 and 24 h of stimulation) using
the guanidinum/phenol extraction procedure [10]. Ten
micrograms of total RNA were separated in 1% formalde-
hyde agarose gel and blotted to a nitrocellulose membrane.
Prehybridization and hybridization were carried out at 65
jC in 1% SDS, 1 M NaCl, 10% dextran sulfate solution.
The cDNA probes for selected genes were amplified using
standard primers for M13 vector which are present in
pTZ57R vector. PCR products were purified (Qiagen) and
labelled with [a-32P]dCTP using the random primer label-
ling kit (Promega). After the washing procedure, RNA blots
were exposed to phosphoimage screen and then read out
using Molecular Imager FX and software Quantity One
(BioRad).
2.7. Calculation of changes in the level of expression
To analyse the results from Multiimage Scanner (RT-
PCR) and Molecular Imager FX (Northern blot analysis),
the densitometric readings of Quantity One software were
calculated using Microsoft Exel. The value of intensity of
each analysed band was divided by the value of intensity
EF2 band for RT-PCR, or 28S for Northern blot analysis,
and the final results were calculated as percentage values of
the control. The reported values represent the mean of three
independent experiments. Statistical analysis was carried out
with the use of t-test.3. Results and discussion
In order to evaluate the transcriptional profile of hepato-
ma cells stimulated with IL-1h, a comprehensive analysis of
cDNA from control and cytokine-treated cells was carried
out using differential display (Fig. 1). To exclude contam-
ination of RNA preparation with DNA, the amplification
procedure was also performed directly on RNA (100 ng)
samples. Using a combination of 10 arbitrary and 9 oli-
go(dT) primers, 90 PCR reactions were completed. Differ-
ent pairs of primers generated various transcript profiles.
Many of these combinations did not yield any differentially
expressed band but, overall, we found 90 IL-1-modulated
cDNA species. All differentially expressed bands, excised
from the gel, were subjected to reamplification but only 46
were successfully reamplified and cloned to pTZ57R vector.
The problems with reamplification of the remaining 44
bands are the consequence of a low expression level result-ing in poor recovery of cDNA from the gel and possible
contamination with acetic acid leading to the inhibition of
Taq polymerase.
All identified transcripts with known full cDNA and
aminoacid sequence could be classified into several groups
according to the function of proteins encoded by these
transcripts: trafficking/motor proteins, proteins participating
in the translation machinery or posttranscriptional/posttrans-
lational modifications, proteases, proteins involved in cel-
lular metabolism, activity modulators, proteins of cell cycle
machinery and those functionally unclassified (Table 1).
Many of the identified genes were represented by more than
one clone, e.g. NADH-ubiquinone oxidoreductase subunit 1
was represented by five clones and subunit 4 by two clones.
Altogether, eight clones matched mitochondrial genes. An-
other group represented by several clones matched genes
involved in the translation machinery: four ribosomal pro-
teins (RPL6, RPL19, RPL26, RPL41), aspartyl-tRNA syn-
thetase and two proteins involved in the posttranscriptional/
posttranslational modifications (protein disulfide isomerase
ERp72 and nuclear binding protein p54nrb).
Changes in the expression of identified genes with a
known function were in all cases confirmed by semiquan-
titative RT-PCR or Northern blot analysis with RNA from
control sample and after IL-1h stimulation for different time
periods (1, 2, 4, 6, 12, 18, 24 h; Fig. 2A-I). Comprehensive
Table 1
Classes of genes responding to IL-1 stimulation in HepG2 cells
GenBank
accession
Classification
Early response genes (1–6 h)
Kinesin family member 5B NM_008448 Trafficking/motor
proteins
Myosin, light polypeptide 6
(MYL6)
NM_079423.1 Trafficking/motor
proteins
Ral guanine nucleotide
dissociation stimulator-like 1
BC039250.1 Activity modulators
Nuclear RNA binding protein
(p54nrb)
XM085471.2 Posttranscription/
posttranslation
modification
Protein disulfide isomerase
related protein (ERp72)
XM170518 Posttranscription/
posttranslation
modification
NADH dehydrogenase subunit 1 AAL54553.1 Metabolism
NADH dehydrogenase subunit 4 BC014376 Metabolism
NADH dehydrogenase subunit 6 NM_173714 Metabolism
Ribosomal protein L41 (RPL41) NM_021104 Protein synthesis
Ribosomal protein L26 (RPL26) AB061829 Protein synthesis
Ribosomal protein L19 (RPL19) NM_000981.2 Protein synthesis
Ribosomal protein L6 (RPL6) NM_000970 Protein synthesis
Aspartyl-tRNA synthetase NM_001349 Protein synthesis
CLL-associated antigen KW-8 AF432221 Functionally
unclassified
NY-REN-45 antigen NM_016121.1 Functionally
unclassified
Chromosome-associated
polypeptide C (hCAP-C)
AB019987.1 Cell cycle
machinery
Apolipoprotein B NM_003900 Metabolism
Short chain alcohol
dehydrogenase (HEP27)
AF244132.1 Metabolism
Glyceraldehyde-3-phosphate
dehydrogenase
BC029618 Metabolism
Late response genes (8–24 h)
Tyrosine 3 monooxygenase/
tryptophan 5-monooxygenase
activation protein
NM_139323.1 Cell cycle machinery
Sequestosome 1
(SQSTM1/p62)
X04506 Activity modulators
Prolonged response (1–24 h)
Cathepsin D (CTSD) NM_001909.3 Proteases (lysosomal
aspartic proteases)
Dynein heavy chain (DNN) AY050643 Trafficking/motor
proteins
MGC20452/EID-2 NM_153232.1 Functionally
unclassified
Prosaposin NM_002778 Metabolism
Expression analysis is not presented for cDNA encoding CoxII/D-loop
DNA fusion protein (L78671). For details see text.
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sure to IL-1h revealed three types of gene response: early
response (1–6 h), late response (12–24 h) and prolonged
response (1–24 h) (Table 1, Figs. 2 and 3).
The trafficking/motor proteins are represented by three
genes encoding one component of the hexameric protein-
alkali light chain-myosin [11], kinesin-family member 5B
[12] and the heavy chain of dynein [13]. Confirmation ofdifferential display analysis by RT-PCR revealed up-regu-
lation of these genes (Figs. 2A and 3A). Myosin and dynein
transcripts show a prolonged increase following IL-1 treat-
ment whereas kinesin represents the early response gene.
Myosin is an important component of muscle cells but is
also essential in the maintenance of cellular structures and
movements of other cells. This protein exists in phosphor-
ylatable and nonphosphorylatable forms which arise from
two different transcription start sites and alternative splicing
of the same gene [14]. So far, the up-regulation of tran-
scription of myosin alkali chain was described in T7D
human breast cancer cells under ethanol exposure [15], so
the response to IL-1 is a novel observation. It is known that
cytoskeletal proteins are important in the progression of
apoptosis [16]; thus, it is possible that the increase in
transcript level of myosin light chain elicited by prolonged
exposure to IL-1 may preceed cell death. Kinesins and
dyneins are involved in movements of organelles within
cells. Using RT-PCR, we observed a prolonged increase of
dynein transcript with 2.5-fold up-regulation after 24 h of
IL-1 exposure. The level of transcript encoding kinesin
increased twofold after 6 h of IL-1 exposure and then
declined to control values after 24 h. Zhu et al. [17]
observed IL-1-induced alteration in cell shape and in the
cytoskeletal organisation of fibroblasts and related them to
the effect of cytoskeleton organisation on the IL-1 signal
transduction. Vinall et al. [18] showed that morphogens (e.g.
bone morphogenetic protein-7) and cytokines (IL-1) change
in chondrocytes the expression level of cytoskeletal pro-
teins, such as tensin, talin, paxillin and focal adhesion
kinase. Such data suggest that probably changes in the
transcript level of other cytoskeletal proteins, so far not
determined, are important in regulation of cell structure
during adaptation to the stress. The genes identified by us
enlarge the group of cytoskeletal proteins directly involved
in IL-1-elicited response.
A prolonged and late increase in the expression level was
observed for cathepsin D, a lysosomal aspartic protease
(Figs. 2B and 3B), important in degradation and processing
of many proteins. Despite extensive research on cathepsin
D, rather little is known about the role of cytokines in its
regulation. Whitaker et al. [19] studied the expression level
of cathepsin D induced by cytokines and leupeptin in
astrocytes. Under serum-free conditions, leupeptin increased
by 1.4–2-fold the protein level and Northern blot analysis
showed concomitant changes in mRNA. By contrast, no
changes were observed in the level of cathepsin D after
exposure of astrocytes to INFg, TNF-a, IL-1h, LPS and
calcium ionophore. Kudo et al. [20] studied in vitro meta-
bolic degradation of human interleukin-1beta (IL-1h) using
lysates of rat kidney lysosomes, and identified proteases
involved in this process. The results suggest that cathepsin
B, cathepsin L, and cathepsin D in kidney lysosomes are
involved in the metabolic degradation of human IL-1h.
Using Northern blot analysis, we found that in HepG2 cells
treated with IL-1, the level of mRNA coding for cathepsin D
Fig. 2. Representative pictures of Northern blots or RT-PCR analysis obtained for the examined genes in the order presented here (A-I). The reference for
Northern blots was 28S rRNA, and for RT-PCR the product of the EF2 gene.
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that this represents a regulatory mechanism to terminate the
stimulatory action of IL-1h.The group of genes coding for proteins participating in
posttranscriptional/posttranlational modifications includes
nuclear binding protein-p54nrb, a product associated with
Fig. 2 (continued).
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tant for folding and/or assembly of proteins: disulfide
isomerase ERp72. Our results indicate that nuclear binding
protein-p54nrb belongs to the group of early response genes
and is up-regulated in HepG2 cells by 1.7-fold after 2 h and
returns to the baseline level after 24 h of IL-1h treatment
(Figs. 2C and 3C). It has been shown that p54nrb interacts
with PSF (polypyrimidine tract binding protein-PTP asso-
ciated splicing factor); these two proteins bind U5snRNA
and are involved in splicing [23]. Ample evidence indicatesthat p54nrb participates not only in RNA splicing but also in
other steps of pre-mRNA processing such as 5V-end cap and
3V-end formation. By binding to the carboxyl terminal
domain (CTD) of the largest subunit of RNA polymerase
II, the nuclear binding protein p54nrb may fold this domain
into a form active in pre-mRNA processing [22].
Another representative of posttranscriptional/posttranla-
tional modification class is ERp72, belonging to the family
of protein disulfide isomerases (PDIs), present in the
endoplasmic reticulum (ER), involved in the formation of
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MGC20452
Fig. 3. Results of densitometric analysis of relative changes in mRNAs abundance as determined by Northern blot or RT-PCR (meanF S.E. of three
independent experiments). Statistical analysis was carried out with the use of t-test; *P< 0.05; **P< 0.025. (A) Trafficking/motor proteins; (B) lysosomal
proteases; (C) proteins involved in posttranscriptional/posttranslational modifications; (D) proteins involved in translation machinery; (E and F) proteins
involved in metabolism; (G) activity modulators; (H) proteins involved in cell cycle machinery; (I) proteins functionally unclassified.
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in the folding and/or assembly of membrane and secretory
proteins [24,25]. The Erp72 mRNA and protein levels were
found to increase in neuroblastoma cells exposed to hyp-
oxia and this corresponded to a neuroprotective effect in
the rat brain ischemia [26]. We observed that after 1 h of
exposure of HepG2 cells to IL-1h, the mRNA level for
ERp72 decreases by 30% in comparison to the control but
then it rises to a maximum at 12–18 h (Figs. 2C and 3C). It
is interesting that the gene important for mRNA processing
is maximally active during the first 2 h of IL-1 exposure,
whereas that one coding for the product involved in protein
modifications reaches the maximal expression later. This
would indicate that regulation of p54nrb and ERp72 genes
controlling the quality of transcripts and final protein
products is important in cell adaptation to stress response
elicited by IL-1h. Although we cannot provide data on the
level of proteins coded by these two genes, it is very likely
that HepG2 cells respond to IL-1h by activating the
machinery responsible for synthesis and processing of
transcripts important in the acute phase response. This is
further supported by the observed changes in the expres-
sion of transcripts encoding ribosomal proteins (RPL6,
RPL19, RPL41) and aspartyl-tRNA synthetase (Figs. 2D
and 3D). It looks that during cytokine-elicited stress, cells
increase the levels of proteins involved in the translation
machinery in order to respond appropriately to the envi-
ronmental changes.
From 36 known genes identified as differentially
expressed in HepG2 cells exposed to IL-1h, seven represent
those involved in cellular energy metabolism. NADH de-
hydrogenase subunits 1, 4 and 6 encoded by mitochondrial
DNA are among 41 polypeptides of respiratory Complex I.
Another transcript encoding HEP27 protein has been al-
ready identified by Heinz et al. [27] as up-regulated during
monocyte to dendritic cell differentiation. The gene contains
two alternative promoter regions: a hepatocyte-specific
promoter induced by the histone deacetylase inhibitor sodi-
um butyrate in several cell types, and a second upstream
promoter which was specifically active in monocyte-derived
dendritic cells. A possible role of the HEP27 protein has yet
to be explained. Gabrielli et al. [28] predicted from cDNA
the amino acid sequence indicating that functional domains
of HEP27 are similar to the SCAD family (short-chain
alcohol dehydrogenase enzymes family). In our study, we
observed up-regulation of HEP27 transcript in HepG2 cells
with a maximum increase after 6 h of IL-1 treatment (2.5–
2.7-fold increase; Figs. 2F and 3F).
Confirmation of the results of differential display by
Northern blot analysis indicates that another transcript
encoding a protein involved in metabolism-prosaposin is
up-regulated, with a 1.8-fold increase after 24 h of IL-1
treatment. Our results indicate that this gene belongs to the
prolonged response genes (Table 1). Prosaposin is present in
the brain and muscle, but processed saposins are found in
the spleen, liver and kidney [29]. Proteolytic cleavage ofprosaposin generates four sphingolipid activator proteins
(saposin A, B, C, D) [30] responsible for the metabolism
of lipids. There is evidence that prosaposin is involved in
signal transduction. Earlier studies showed an up-regulation
of prosaposin in differential display screening of mRNA
extracted from breast cancer cell lines (T47D, MCF7) after
treatment with HPR (N-4-hydroxyphenylretinamide), a syn-
thetic retinoid which has antiproliferative and apoptotic
effects in vitro against several malignant cell lines. Panigone
et al. [31] suggested that chemopreventive activity of HPR
arises from its effect via prosaposin on integrin receptors,
which are down-regulated resulting in reduced metastatic
activity of tumor cells. It was also shown that prosapeptides,
synthetic peptides (14–22 residues) from the C domain,
induce differentiation and prevent cell death in a variety of
neuronal cells [32,33]. Their action leads to enhanced
phosphorylation of mitogen-activated kinases in Schwann
cells, ERK1 and ERK2, which are involved in the MAPK
pathway [34]. In many cellular systems, MAPK activation
leads to changes in gene expression, especially the genes
associated with cellular proliferation and differentiation
[35]. Our data showing up-regulation of prosaposin mRNA
may provide additional evidence that IL-1h activates mo-
lecular mechanisms essential for cell survival rather than
apoptosis.
Other proteins involved in cellular metabolism and
affected by IL-1h in HepG2 cells include apolipoprotein
B and glyceraldehyde-3-phosphate dehydrogenase (Table
1). Yokoyama et al. [36] observed a significant increase in
apoB mRNA after 1 h of stimulation of HepG2 cells with
IL-1 while the maximum mRNA level was reached 3 h after
stimulation and persisted for up to 18 h. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) is a glycolytic enzyme
involved in cytosolic energy production. Aldred and
Schreiber [37] showed that the level of mRNA for GAPDH
is decreased after induction of acute inflammation during
the first 80 h, suggesting that proinflammatory cytokines
affect cellular glucose degradation. Using Northern blot
analysis, we observed a down-regulation of GAPDH (Figs.
2F and 3F). Regulation of genes involved in glucose
metabolism is probably of physiological relevance since
IL-1 is known to affect the energy balance [38].
The results of both differential display analysis and
Northern blot indicate the up-regulation of mRNA coding
for sequestosome 1 (SQSTM1/p62), a protein which non-
covalenly binds ubiquitin [39]. Ubiquitination of cellular
proteins is an important step initiating degradation of many
proteins such as cell surface receptors, mitotic cyclins,
oncoproteins, transcription regulators such as InB, NFnB,
c-Jun and c-Fos and tumor suppressor p53 [39]. Sanz et al.
[40] showed that p62 interacts with atypical kinase C
(aPKC) which is important in cell proliferation and survival.
p62 mediates intracellular signalling through the IL-1/TNF
pathways towards NFnB known to have a protective role by
inducing antiapoptotic factors [41]. Down-regulation of p62
severely reduces NFnB activation by IL-1 and TRAF6 [40].
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tosome 1 is from the category of late response genes under
IL-1 stimulation. It is possible that activation of p62 is
promoted by aggregation and sequestration of abnormal
proteins. Increased amounts of unfolded or misfolded pro-
teins are observed in pathogenesis of many diseases [42]. It
may be expected that such phenomena occur frequently
during a stress response and up-regulation of p62 after IL-1
exposure helps to protect cells against accumulation of
inappropriately folded proteins. The formation of Mallory
bodies (MB), considered as a pathological form of seques-
tosome, has been observed in alcoholic hepatitis and other
liver disorders. The MBs consist of abnormal proteins
(keratins), heat shock proteins (HSP25, HSP70 and
HSP70) and also of p62. The role of p62 in MBs formation
is unclear but, undoubtedly, it takes part in ubiquitination of
proteins assigned for degradation.
To the group of signal transducers belongs also Ral
guanine nucleotide dissociation stimulator-like 1 (RGL),
involved in Ras and Ral signalling pathways as a down-
stream effector protein [43]. RGL transcript is highly up-
regulated under IL-1h exposure: we observed a biphasic
response with the maximum after 4 and 24 h (Figs. 2G and
3G). Nothing is known about the function of this protein in
acute phase response but, according to reports of Ljungdahl
et al. [44], NFnB is a downstream mediator of Ras signaling
pathway. Thus, we suggest that RGL activation may pro-
mote cell survival and acute phase protein synthesis.
The last group of identified transcripts with a known
function includes proteins involved in cell cycle machinery
(Figs. 2H and 3H). Tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein (YWHAB) belongs to
the 14-3-3 family, highly conserved from bacteria to
humans and plants. Proteins that interact with 14-3-3 iso-
forms are involved in signal transduction by binding to
phosphoserine/threonine-containing proteins, and thus af-
fect cell cycle regulation, cell survival, apoptosis, prolifer-
ation and stress response [45,46]. We observed over
twofold up-regulation of YWHAB mRNA after 12 h of
IL-1 exposure. Recently, it was shown that 14-3-3q protein
encoded by YWHAE gene is important in brain develop-
ment and neuronal migration [46]. It would be interesting to
analyse function of YWHAB protein in macrophages since
probably it is important for macrophage migration during
inflammation.
Another transcript belonging to the cell cycle machinery
codes for chromosome-associated polypeptide C, belonging
to the multiprotein complex: 13S condensin. The complex
plays a key role in chromosome condensation and segre-
gation in mitosis. We observed 1.7-fold up-regulation of
this transcript after 4 h of IL-1 treatment followed by a
decrease after 12 h in comparison with control (Figs. 2H
and 3H). Hagstrom and Meyer [47] reported recently that
condensin interacts also with different sets of proteins
performing various roles, such as regulation of gene ex-
pression, participation in the DNA-damage checkpoint-signalling pathway and organization and orientation of the
centromere.
In the group of transcripts encoding proteins functionally
not characterized, we observed modulated expression for a
hypothetical protein MGC20452, NY-REN-45 antigen,
CLL-associated antigen KW8 and a transcript encoding
CoxII/D-loop fusion protein. Recently, Ji et al. [48] reported
that MGC20452 protein (renamed EID-2) is involved in
skeletal muscle differentiation. This nuclear protein has the
ability to associate with p300 and inhibit its acetyltransfer-
ase activity. EID-2 is a homologous protein to EID-1 which
is also responsible for the inhibition of skeletal muscle-
specific transcription through association with p300 [49].
We observed that IL-1 stimulation leads to a prolonged
decrease in EID-2 transcript level (Figs. 2I and 3I). This
suggests that EID-2 is in fact not a skeletal muscle specific
protein but is responsible for transcription inhibition in
HepG2 cells under IL-1 exposure. It would be interesting
to define what kind of transcriptional coactivators with
histone acetyltransferase activity interact with EID-2. An-
other transcript, NY-REN-45 antigen, was earlier cloned by
screening of cDNA libraries derived from renal cell carci-
noma with autologous antibody (SEREX) [50]. The anti-
gens detected by SEREX method represented proteins with
different functions: transcription factors, DNA and RNA
binding proteins, metabolic enzymes, molecular chaperones,
cytoskeletal proteins, membrane-associated proteins. The
novel antigen REN-45 cDNA consists of a 4.42-kb tran-
script with 2445 nucleotides of the open reading frame. The
function of this protein has to be studied, but amino acid
composition shows certain similarity to potassium channel
proteins with several nuclear signals and single transmem-
brane domain [50], so it is possible that under specific
stimulation, the protein can be translocated to the nucleus.
We observed 1.6–1.7-fold increase of mRNA NY-REN-45
after a 6-h exposure to IL-1.
Using BLAST search, we found that one of the detected
transcripts matched CLL-associated antigen KW8 [51] and
carboxyl terminus of Hsc70-interacting proteins (CHIP)
cDNA. Both transcripts have the same sequence, which
was identified in different laboratories with the use of
various methods. CHIP was identified by the yeast two-
hybrid screen as a protein interacting with Hsp70 and
Hsc70. A characteristic feature of this protein depends on
the presence of the tetratricopeptide repeat domain, typical
for proteins with many cellular functions, such as mitosis,
protein transport and development [52]. For heat shock
proteins, several such chaperone cofactors were identified
with a tetratricopeptide repeat domain. These proteins
participate in regulation of protein folding and transport.
The suggested role for CHIP is mediation of interactions
between chaperoning and ubiquitin-proteasome systems
[52]. We observed around 1.5-fold increase of the transcript
coding for CHIP protein after 6 h of IL-1h stimulation (Figs.
2I and 3I). More detailed data are needed to elucidate
whether both transcripts, NY-REN-45 antigen and CHIP
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IL-1 signal transduction pathway in HepG2 cells.
We are not presenting the expression analysis data for the
transcript encoding CoxII/D-loop fusion protein. This is a
novel fusion cDNA generated by an 8037-bp deletion in
mitochondrial DNA. The deletion encompasses the cyto-
chrome oxidase II gene (nt 8030–8034) and the D-loop
region (nt 16071–16075) and is observed in various dis-
eases and during aging [53]. From several Northern blot
experiments done for this transcript, only one was readable
while the rest presented unspecific hybridization with three
bands visible. They may have appeared because not all cells,
and not all mitochondria, contain the big deletion (hetero-
plasmy) and therefore the molecular probe used in our
experiments could hybridize to different mitochondrial or
genomic transcripts.
Changes in the transcript level of RPL26 in the IL-1-
activated HepG2 cells were also not analysed in our experi-
ments since modulated synthesis of this ribosomal compo-
nent in response to different activators in various cell lines
has been already described by many authors [54,55]. For
this reason, our expression studies were limited to tran-
scripts encoding RPL6, RPL19 and RPL41. The third
protein presented in Table 1 and not analysed by RT-PCR
or Northern blot is apolipoprotein B. As mentioned above,
the detailed expression studies for ApoB were done by
Yokoyama et al. [36].
Ten of forty-six templates identified by us in differential
display as modulated by IL-1h had no homology with
known and functionally classified genes deposited in Gen-
Bank entries. We are planning to study these sequences in
the near future since these yet uncharacterized transcripts
can be involved in specific acute phase response of HepG2
cells stimulated by IL-1h. Using Northern blot analysis, we
have already confirmed that four of these transcripts are
indeed modulated by exposure of HepG2 cells to IL-1 for
different time periods (data not shown).
In the described experiments, we have not detected
changes in the mRNAs coding for any of the main tran-
scription factors, probably because of their very low abun-
dance in a cell. According to Jongeneel et al. [56], many
transcription factors are coded for by less than 10 mRNA
copies per cell. The great majority of highly expressed genes
are housekeeping genes responsible for cytoskeletal struc-
tures or enzymes involved in protein synthesis and energy
metabolism [57].
One should remember that differential display analysis
belongs to indirect screening methods. Primers used in PCR
reaction are not specific to any cDNA and low stringency
conditions enable annealing them to various accidental
templates. Also for this reason, not all transcripts known
to be modulated by IL-1 treatment have been amplified and
visible on polyacrylamide gel. We were not able to detect
transcripts encoding metallothionein 1 and 2 [58], phos-
pholipase A2 [59], ferritin [60] and many other genes
described earlier as regulated by IL-1 in HepG2 cells. Thisis clearly an inherent weakness of the differential display
analysis.
We are aware that the use of microarray technique might
yield a different transcriptome profile of gene expression in
HepG2 cells stimulated with IL-1h. The chip technology is
a powerful method which permits to monitor the activity of
several thousand of genes but the results are difficult to
standardize and interpret. In our case, the pattern of expres-
sion of 25 genes of known function that are modulated by
IL-1 exposure was confirmed by Northern blot and/or RT-
PCR in three independent experiments involving three
separate cultures used for isolation and analysis of RNA
(cf. Figs. 2 and 3). Thus, our results clearly indicate that
differential display is a useful method of screening for
changes of expression of several genes. However, the final
proof of real differences in gene expression will be only
possible after evaluating the corresponding proteome pro-
file. This requires measuring changes in the level of indi-
vidual proteins coded by specific mRNAs and we are
currently engaged in such studies.
In conclusion, differential display analysis permits to
detect subtle changes in the IL-1-induced gene expression
in cultured human hepatoma cells, provided the changes in
the level of individual transcripts are verified by Northern
blot or RT-PCR. The technique is also useful in detecting
IL-1-responsive genes of as yet unknown function but with
sufficiently abundant transcripts. We have identified 10 of
such gene transcripts in HepG2 cells stimulated with IL-1.
On the other hand, differential display, being based on
accidental annealing of arbitrarily designed primers, may
miss altogether some important components of the tran-
scriptome. The transcripts identified by us in differential
display analysis of HepG2 cells were stimulated with IL-1
encode cytoplasmic and nuclear proteins but not secreted
proteins from the class of acute phase reactants. The latter
are affected mainly by IL-6 or by a synergistic action of IL-1
and IL-6 (see Refs. [3,61]). It appears that the cellular
response to IL-1 promotes the process of cell survival and
adaptation by up-regulating the early response genes play-
ing an important role in cytoskeletal organisation, cellular
metabolism, protein synthesis, posttranscriptional and post-
tranlational modifications and cell cycle machinery. As the
late response genes are activated those responsible for the
control of protein quality. A few genes—those coding for
cathepsin D, dynein and prosaposin—represent the pro-
longed response under IL-1 stimulation. Clearly, further
studies employing different methods of transcriptome and
proteome analysis are needed to verify and expand the
results reported here.Acknowledgements
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